Skip to main content

1 Result(s)

within Reshma Reji Remove this filter

and

  1. No Access

    Article

    Efficacy and safety of curcumin in maintaining remission during disease-modifying antirheumatic drug withdrawal in rheumatoid arthritis at 52 weeks: a phase III double-blind, randomized placebo-controlled trial

    Curcumin has anti-inflammatory properties but current evidence is limited to advocate its use in rheumatoid arthritis (RA). We explored whether curcumin could maintain remission in patients with RA while taper...

    Sreeja S. Bhat, Sakir Ahmed, Reshma Reji, Pankti Mehta… in Rheumatology International (2023)